相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma
Ines Pires da Silva et al.
CLINICAL CANCER RESEARCH (2019)
Tumor mutational burden and response to programmed cell death protein 1 inhibitors in a case series of patients with metastatic desmoplastic melanoma
Lise Boussemart et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
High response rate to PD-1 blockade in desmoplastic melanomas
Zeynep Eroglu et al.
NATURE (2018)
Melanoma subtypes demonstrate distinct PD-L1 expression profiles
Genevieve J. Kaunitz et al.
LABORATORY INVESTIGATION (2017)
NF1-mutated melanoma tumors harbor distinct clinical and biological characteristics
Helena Cirenajwis et al.
MOLECULAR ONCOLOGY (2017)
Whole-genome landscapes of major melanoma subtypes
Nicholas K. Hayward et al.
NATURE (2017)
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
Martin Lauss et al.
NATURE COMMUNICATIONS (2017)
Emergence of CTNNB1 mutation at acquired resistance to KIT inhibitor in metastatic melanoma
J. Cho et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2017)
Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma
Katja Harbst et al.
CANCER RESEARCH (2016)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas
Michael Krauthammer et al.
NATURE GENETICS (2015)
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway
A. Hunter Shain et al.
NATURE GENETICS (2015)
The Genetic Evolution of Melanoma from Precursor Lesions
A. Hunter Shain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
Nicholas McGranahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
The BRAF V600K Mutation Is More Frequent than the BRAF V600E Mutation in Melanoma In Situ of Lentigo Maligna Type
Eike Stadehneyer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Molecular and genetic diversity in the metastatic process of melanoma
Katja Harbst et al.
JOURNAL OF PATHOLOGY (2014)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Geometric Staged Excision for the Treatment of Lentigo Maligna and Lentigo Maligna Melanoma
Mark Abdelmalek et al.
ARCHIVES OF DERMATOLOGY (2012)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma
Alexander M. Menzies et al.
CLINICAL CANCER RESEARCH (2012)
Melanoma genome sequencing reveals frequent PREX2 mutations
Michael F. Berger et al.
NATURE (2012)
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Michael Krauthammer et al.
NATURE GENETICS (2012)
Molecular Mechanisms of Ultraviolet Radiation-Induced DNA Damage and Repair
Rajesh P. Rastogi et al.
JOURNAL OF NUCLEIC ACIDS (2010)
Divergent Cancer Pathways for Early-Onset and Late-Onset Cutaneous Malignant Melanoma
William F. Anderson et al.
CANCER (2009)
Somatic activation of KIT in distinct subtypes of melanoma
John A. Curtin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Histologic criteria for diagnosing primary cutaneous malignant melanoma
BR Smoller
MODERN PATHOLOGY (2006)
Distinct sets of genetic alterations in melanoma
JA Curtin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Non-invasive analysis of melanoma thickness by means of dermoscopy: a retrospective study
M Stante et al.
MELANOMA RESEARCH (2001)
Preoperative assessment of melanoma thickness by ABCD score of dermatoscopy
P Carli et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)